Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 1;17(11):1810.
doi: 10.3390/ijms17111810.

The Neuroprotective Properties of Hericium erinaceus in Glutamate-Damaged Differentiated PC12 Cells and an Alzheimer's Disease Mouse Model

Junrong Zhang  1 , Shengshu An  2 , Wenji Hu  3 , Meiyu Teng  4 , Xue Wang  5 , Yidi Qu  6 , Yang Liu  7 , Ye Yuan  8 , Di Wang  9
Affiliations

The Neuroprotective Properties of Hericium erinaceus in Glutamate-Damaged Differentiated PC12 Cells and an Alzheimer's Disease Mouse Model

Junrong Zhang et al. Int J Mol Sci. .

Abstract

Hericium erinaceus, an edible and medicinal mushroom, displays various pharmacological activities in the prevention of dementia in conditions such as Parkinson's and Alzheimer's disease. The present study explored the neuroprotective effects of H. erinaceus mycelium polysaccharide-enriched aqueous extract (HE) on an l-glutamic acid (l-Glu)-induced differentiated PC12 (DPC12) cellular apoptosis model and an AlCl₃ combined with d-galactose-induced Alzheimer's disease mouse model. The data revealed that HE successfully induced PC12 cell differentiation. A 3 h HE incubation at doses of 50 and 100 µg/mL before 25 mM of l-Glu effectively reversed the reduction of cell viability and the enhancement of the nuclear apoptosis rate in DPC12 cells. Compared with l-Glu-damaged cells, in PC12 cells, HE suppressed intracellular reactive oxygen species accumulation, blocked Ca2+ overload and prevented mitochondrial membrane potential (MMP) depolarization. In the Alzheimer's disease mouse model, HE administration enhanced the horizontal and vertical movements in the autonomic activity test, improved the endurance time in the rotarod test, and decreased the escape latency time in the water maze test. It also improved the central cholinergic system function in the Alzheimer's mice, demonstrated by the fact that it dose-dependently enhanced the acetylcholine (Ach) and choline acetyltransferase (ChAT) concentrations in both the serum and the hypothalamus. Our findings provide experimental evidence that HE may provide neuroprotective candidates for treating or preventing neurodegenerative diseases.

Keywords: Alzheimer‘s disease mouse; Hericium erinaceus; glutamate; mitochondria; neuro-protection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) HE and NGF induced PC12 cell differentiation determined by inverted microscope. Scale bar: 100 µm. (n = 6); (B) HE and NGF enhanced the expressions of β-tubulin III in PC12 cells. Data are expressed as mean ± SD (n = 6). * p < 0.05 and ** p < 0.01 vs. CTRL, HE: Hericium erinaceus aqueous extract; NGF: Nerve growth factor; CTRL: Non-treated cells.
Figure 2
Figure 2
(A) HE showed no effects on cell proliferation in normal DPC12 cells; (B) but strongly enhanced cell viability in l-Glu-induced DPC12 cellular apoptosis model; (C) HE restored l-Glu-induced nucleus morphological apoptotic alterations analyzed via Hoechst 33342 staining (n = 6). Scale bar: 100 µm. HE: Hericium erinaceus aqueous extract. Data are expressed as mean ± SD (n = 6). ### p < 0.001 vs. CTRL, ** p < 0.01 and *** p < 0.001 vs. l-Glu-exposed cells. HE: Hericium erinaceus aqueous extract; CTRL: Non-treated cells.
Figure 3
Figure 3
(A) The disruption of mitochondrial membrane potential (MMP) caused by 12 h l-Glu exposure was strongly restored by 3 h HE pretreatment analyzed via JC-1 staining (n = 6). Scale bar: 100 µm; (B) the overaccumulation of reactive oxygen species (ROS) caused by 12 h l-Glu exposure was significantly reduced by 3 h HE pretreatment analyzed by DCFH-DA (2’,7’-dichlorofluorescein diacetate) staining (n = 6). Scale bar: 100 µm; (C) intracellular Ca2+ overload caused by l-Glu was strongly reversed by 3 h HE pretreatment analyzed via Fluo-4-AM staining (n = 6). Scale bar: 100 µm. Data are expressed as mean ± SD (n = 6). ### p < 0.001 vs. CTRL, *** p < 0.001 vs. l-Glu-exposed cells. HE: Hericium erinaceus aqueous extract; CTRL: Non-treated cells.
Figure 3
Figure 3
(A) The disruption of mitochondrial membrane potential (MMP) caused by 12 h l-Glu exposure was strongly restored by 3 h HE pretreatment analyzed via JC-1 staining (n = 6). Scale bar: 100 µm; (B) the overaccumulation of reactive oxygen species (ROS) caused by 12 h l-Glu exposure was significantly reduced by 3 h HE pretreatment analyzed by DCFH-DA (2’,7’-dichlorofluorescein diacetate) staining (n = 6). Scale bar: 100 µm; (C) intracellular Ca2+ overload caused by l-Glu was strongly reversed by 3 h HE pretreatment analyzed via Fluo-4-AM staining (n = 6). Scale bar: 100 µm. Data are expressed as mean ± SD (n = 6). ### p < 0.001 vs. CTRL, *** p < 0.001 vs. l-Glu-exposed cells. HE: Hericium erinaceus aqueous extract; CTRL: Non-treated cells.
Figure 4
Figure 4
In AlCl3- and d-gal-induced AD mice, four-week HE treatment strongly enhanced (A) horizontal movements and (B) vertical movements in locomotor activity test; (C) increased the endurance time in rotating test; and (D) reduced the escape latency time in water-maze test compared with nontreated model mice. Data are expressed as mean ± SD (n = 10). ### p < 0.001 vs. normal mice (CTRL), ** p < 0.01 and *** p < 0.001 vs. AD mice. HE: Hericium erinaceus aqueous extract.
Figure 5
Figure 5
HE treated AlCl3- and d-gal-induced AD mice for four weeks, and blood and hypothalamus were collected. The levels of (A) acetylcholine (Ach) and (C) choline acetyltransferase (ChAT) in hypothalamus, and the levels of (B) Ach and (D) ChAT in serum were detected via ELISA method. Data are expressed as the percentage to controls and mean ± SD (n = 10). ### p < 0.001 vs. normal mice (CTRL), * p <0.05 and ** p < 0.01 vs. AD mice. HE: Hericium erinaceus aqueous extract.
Figure 6
Figure 6
The experimental protocol for AlCl3- and d-gal-induced Alzheimer’s disease mouse model establishment and drug administration.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sica R.E. Could astrocytes be the primary target of an offending agent causing the primary degenerative diseases of the human central nervous system? A hypothesis. Med. Hypotheses. 2015;84:481–489. doi: 10.1016/j.mehy.2015.02.004. - DOI - PubMed
    1. Chang C.H., Chen Y., Yew X.X., Chen H.X., Kim J.X., Chang C.C., Peng C.C., Peng R.Y. Improvement of erinacine a productivity in Hericium erinaceus mycelia and its neuroprotective bioactivity against the glutamate-insulted apoptosis. LWT-Food Sci. Technol. 2016;65:1100–1108. doi: 10.1016/j.lwt.2015.08.014. - DOI
    1. Bermejo-Pareja F., Llamas-Velasco S., Villarejo-Galende A. Alzheimer’s disease prevention: A way forward. Rev. Clin. Esp. 2016;65:1100–1108. doi: 10.1016/j.rceng.2016.06.006. - DOI - PubMed
    1. Rosello A., Warnes G., Meier U.C. Cell death pathways and autophagy in the central nervous system and its involvement in neurodegeneration, immunity and central nervous system infection: To die or not to die—That is the question. Clin. Exp. Immunol. 2012;168:52–57. doi: 10.1111/j.1365-2249.2011.04544.x. - DOI - PMC - PubMed
    1. Karbowski M., Neutzner A. Neurodegeneration as a consequence of failed mitochondrial maintenance. Acta Neuropathol. 2012;123:157–171. doi: 10.1007/s00401-011-0921-0. - DOI - PubMed

MeSH terms

LinkOut - more resources